Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

14.15
Delayed Data
As of Aug 16
 +0.25 / +1.80%
Today’s Change
8.31
Today|||52-Week Range
32.74
-2.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues5.8B8.3B10.4B9.7B
 
 
 
 
 
Cost of Goods Sold1.8B2.1B2.4B2.4B
 
 
 
 
 
Depreciation And Amortization1.4B1.7B2.5B2.9B
 
 
 
 
 
 
Operating ExpensesGross Income2.6B4.5B5.6B4.4B
 
 
 
 
 
General Expenses1.5B2.3B3.0B3.2B
 
 
 
 
 
Other Operating Expenses174.2M0.0063.1M0.00
 
 
 
Research And Development156.8M246.0M334.4M421.0M
 
 
 
 
 
Total Operating Expenses4.8B6.0B7.9B8.5B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income979.6M2.3B2.5B1.2B
 
 
 
 
 
Extraordinary Credit--64.1M--13.0M
 
 
 
Extraordinary Charge-1.4B-725.0M-993.8M-1.7B
 
 
 
 
 
Interest Expense On Debt844.3M971.0M1.6B1.9B
 
 
 
 
 
Other Expenses-13.8M446.0M-102.8M-53.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.3B1.1B-155.3M-2.4B
 
 
 
 
 
Income Taxes-450.8M-180.4M-132.5M-27.0M
 
 
 
 
 
Minority Interest-2.5M-1.3M-3.9M-1.0M
 
 
 
 
 
Net Income-866.1M913.5M-291.7M-2.4B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS321.0M335.4M342.7M347.3M
 
 
 
 
 
Shares To Calculate EPS Diluted321.0M341.5M342.7M347.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.70$2.72-$0.85-$6.94
 
 
 
 
 
EPS Diluted-$2.70$2.67-$0.85-$6.94